Do the patients with MCI also have mild Alzheimers? Orrrr, extra mild Alzheimers? What differentiates them with the patients in the mild-moderate group that have mild symptoms?
AVXL 2-73 is better than Aricept if this clinical trial only shows that there is no significantly statistical cognitive decline patients in the trial at 52 weeks or even if there is a decline in MMSE scoring of less than 3.
AVXL 2-73 is also better than Aricept if it shows and continues to show this:
'Therapeutic Response Unexpected'. A sample of verbatim terms reported include: Improved Engagement with Family/Friends Improvement in Mood Increased Independent Activity Feeling Happier Improved Alertness Better Coordination Better Coping